ERA-EDTA Congress 2011: Late Breaking Clinical Trials I - PR Newswire (press release) PDF Print

ERA-EDTA Congress 2011: Late Breaking Clinical Trials I
PR Newswire (press release)
in four different groups. Significant improvements in GFR were reported in all the bardoxolone groups compared to the placebo group (p<0.001). Other renal function parameters (creatinine and urea) were also better in the Bardoxolone group.

and more »

...

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.